Workflow
Reproductive technology
icon
Search documents
INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing
GlobeNewswire News Room· 2025-07-09 13:00
SARASOTA, Fla., July 09, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare company focused on the fertility market, today announced further efforts to drive its comprehensive strategy to enhance fertility services through expanded clinical and embryology training support and improved pricing for its innovative INVOcell® technology. This underscores the Company’s dual mission as an innovator of cutting-edge fertility solutions and a provider of comp ...
INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute
Globenewswire· 2025-06-30 13:00
MIDDLETON, Wis. and SARASOTA, Fla., June 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare company focused on the fertility market, is excited to announce the addition of Platelet-Rich Plasma (PRP) therapy to its comprehensive suite of fertility services at its Wisconsin Fertility Institute center. This cutting-edge treatment offers additional options for individuals and couples facing fertility challenges, further expanding the center's commit ...
A New Era for Embryo Screening: Juniper Genomics Debuts with World's First Whole-Genome and Transcriptome Test
GlobeNewswire News Room· 2025-06-26 12:00
Toronto, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Juniper Genomics, a health-tech company pioneering a new standard of care in IVF, today announced its public launch alongside a $4.6 million seed round led by Company Ventures, with participation from Innospark Ventures, MBX Capital, Amboy Street Ventures, Dria Ventures, and Blue Collective. Founded by experts in genomics, reproductive medicine, and bioethics—Jeremy Grushcow, PhD, JD (CEO), Carolyn Quinlan, MSc (VP of Bioethics), and Dr. Lee Shulman (Medic ...
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
GlobeNewswire News Room· 2025-06-25 13:00
SARASOTA, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare company focused on the fertility sector, today announced it has received a notice of allowance on a new patent for a modified version of the Company's proprietary INVOcell device. The new patent extends intellectual property protection on the Company's INVOcell device through 2040 based on a modified design which reflects feedback from leading embryologists to simplify use o ...
INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern Time
Globenewswire· 2025-06-20 13:00
SARASOTA, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility focused company, reminds shareholders to vote their shares online ahead of the upcoming annual meeting of shareholders (the "Annual Meeting") to be held on June 25, 2025 at 12:00 p.m. Eastern Time. The Board of Directors (the "Board") unanimously recommends that the Company's shareholders vote "FOR" all proposals. Only shareholders of record as of the close of busi ...
INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute
GlobeNewswire News Room· 2025-06-18 13:00
To learn more about Wisconsin Fertility Institute, visit www.Wisconsinfertility.com or contact the clinic at 608- 824-0075 for more details. About INVO Fertility MIDDLETON, Wis. and SARASOTA, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, is thrilled ...
INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute
Globenewswire· 2025-06-18 13:00
This telehealth platform allows prospective parents to connect with Wisconsin Fertility Institute's team of providers from the comfort of their homes. Through secure virtual consultations, patients can receive personalized fertility assessments, treatment planning, and ongoing support, making high-quality care more accessible and convenient than ever before. "Our mission has always been to empower families with the tools and expertise they need to achieve their dreams of parenthood," said Steve Shum, CEO at ...
INVO Fertility’s Wisconsin Clinic Recognized on Newsweek’s List of America’s Best Fertility Clinics for 2025
Globenewswire· 2025-06-16 13:00
MIDDLETON, Wis. and SARASOTA, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced that its Wisconsin Fertility Institute clinic has been included on Newsweek’s list of America’s Best Fertility Clinics for 2025. The America’s Best Fertility ...
INVO Fertility's Wisconsin Clinic Recognized on Newsweek's List of America's Best Fertility Clinics for 2025
GlobeNewswire News Room· 2025-06-16 13:00
MIDDLETON, Wis. and SARASOTA, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced that its Wisconsin Fertility Institute clinic has been included on Newsweek’s list of America’s Best Fertility Clinics for 2025. The America’s Best Fertility ...
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
Globenewswire· 2025-05-27 21:00
SARASOTA, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, will participate in a webcast fireside chat and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference, taking place virtually on Thursday, May 29 ...